ATE432262T1 - Pyrazolphenylderivate als ppar-aktivatoren - Google Patents
Pyrazolphenylderivate als ppar-aktivatorenInfo
- Publication number
- ATE432262T1 ATE432262T1 AT05735100T AT05735100T ATE432262T1 AT E432262 T1 ATE432262 T1 AT E432262T1 AT 05735100 T AT05735100 T AT 05735100T AT 05735100 T AT05735100 T AT 05735100T AT E432262 T1 ATE432262 T1 AT E432262T1
- Authority
- AT
- Austria
- Prior art keywords
- pyrazolephenyl
- derivatives
- ppar activators
- ppar
- compounds
- Prior art date
Links
- 102000003728 Peroxisome Proliferator-Activated Receptors Human genes 0.000 title 1
- 108090000029 Peroxisome Proliferator-Activated Receptors Proteins 0.000 title 1
- 239000012190 activator Substances 0.000 title 1
- 150000001875 compounds Chemical class 0.000 abstract 2
- 102000023984 PPAR alpha Human genes 0.000 abstract 1
- 108010015181 PPAR delta Proteins 0.000 abstract 1
- 239000000556 agonist Substances 0.000 abstract 1
- 230000006806 disease prevention Effects 0.000 abstract 1
- 150000002148 esters Chemical class 0.000 abstract 1
- 238000000034 method Methods 0.000 abstract 1
- 108091008725 peroxisome proliferator-activated receptors alpha Proteins 0.000 abstract 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
- C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
- C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D231/12—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/18—Drugs for disorders of the alimentary tract or the digestive system for pancreatic disorders, e.g. pancreatic enzymes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/08—Drugs for disorders of the urinary system of the prostate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- General Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Dermatology (AREA)
- Urology & Nephrology (AREA)
- Endocrinology (AREA)
- Biomedical Technology (AREA)
- Reproductive Health (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Rheumatology (AREA)
- Vascular Medicine (AREA)
- Emergency Medicine (AREA)
- Pain & Pain Management (AREA)
- Psychiatry (AREA)
- Gynecology & Obstetrics (AREA)
- Pregnancy & Childbirth (AREA)
- Hospice & Palliative Care (AREA)
- Child & Adolescent Psychology (AREA)
- Gastroenterology & Hepatology (AREA)
- Immunology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Physical Education & Sports Medicine (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP04101792 | 2004-04-28 | ||
| PCT/EP2005/004199 WO2005105754A1 (en) | 2004-04-28 | 2005-04-20 | Pyrazole phenyl derivatives as ppar activators |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE432262T1 true ATE432262T1 (de) | 2009-06-15 |
Family
ID=34965271
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT05735100T ATE432262T1 (de) | 2004-04-28 | 2005-04-20 | Pyrazolphenylderivate als ppar-aktivatoren |
Country Status (14)
| Country | Link |
|---|---|
| US (3) | US20050245589A1 (de) |
| EP (1) | EP1742923B1 (de) |
| JP (1) | JP4733692B2 (de) |
| KR (1) | KR100815691B1 (de) |
| CN (1) | CN1946698B (de) |
| AT (1) | ATE432262T1 (de) |
| AU (1) | AU2005238163A1 (de) |
| BR (1) | BRPI0510451A (de) |
| CA (1) | CA2563461C (de) |
| DE (1) | DE602005014629D1 (de) |
| ES (1) | ES2324674T3 (de) |
| MX (1) | MXPA06012093A (de) |
| RU (1) | RU2384573C2 (de) |
| WO (1) | WO2005105754A1 (de) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR101922515B1 (ko) | 2006-09-08 | 2019-02-20 | 로드아일랜드하스피틀 | 알코올 유발성 간 질환의 치료, 예방 및 역행 |
| KR20090066289A (ko) | 2006-09-08 | 2009-06-23 | 로드아일랜드하스피틀 | 알코올 유발성 뇌 질환의 치료, 예방 및 역행 |
| EP2114396A4 (de) | 2006-12-29 | 2010-03-10 | Salk Inst For Biological Studi | Verfahren zur verbesserung der trainingsleistung |
| CN102202672A (zh) | 2008-10-10 | 2011-09-28 | 达拉生物科学公司 | 使用穗霉素衍生物治疗或预防疼痛的方法 |
| CN103298469A (zh) | 2010-08-31 | 2013-09-11 | 首尔大学校产学协力财团 | PPARδ激动剂的胎儿重编程的用途 |
| WO2015061481A1 (en) | 2013-10-23 | 2015-04-30 | Dara Biosciences, Inc. | Methods of treating liquid tumors using compositions comprising spicamycin derivatives |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2001016120A1 (en) * | 1999-08-27 | 2001-03-08 | Eli Lilly And Company | Biaryl-oxa(thia)zole derivatives and their use as ppars modulators |
| JP2003171275A (ja) * | 2001-12-11 | 2003-06-17 | Sumitomo Pharmaceut Co Ltd | PPARδアゴニスト |
| JP2003292439A (ja) * | 2002-02-04 | 2003-10-15 | Sumitomo Pharmaceut Co Ltd | 新規ピロール誘導体からなるppar活性化剤 |
| GB0214139D0 (en) * | 2002-06-19 | 2002-07-31 | Glaxo Group Ltd | Chemical compounds |
| US20060241157A1 (en) * | 2003-01-06 | 2006-10-26 | Conner Scott E | Heterocyclic ppar modulators |
-
2005
- 2005-04-20 AT AT05735100T patent/ATE432262T1/de active
- 2005-04-20 RU RU2006141686/04A patent/RU2384573C2/ru not_active IP Right Cessation
- 2005-04-20 KR KR1020067022284A patent/KR100815691B1/ko not_active Expired - Fee Related
- 2005-04-20 MX MXPA06012093A patent/MXPA06012093A/es active IP Right Grant
- 2005-04-20 EP EP05735100A patent/EP1742923B1/de not_active Expired - Lifetime
- 2005-04-20 JP JP2007509926A patent/JP4733692B2/ja not_active Expired - Fee Related
- 2005-04-20 AU AU2005238163A patent/AU2005238163A1/en not_active Abandoned
- 2005-04-20 DE DE602005014629T patent/DE602005014629D1/de not_active Expired - Lifetime
- 2005-04-20 CN CN2005800132442A patent/CN1946698B/zh not_active Expired - Fee Related
- 2005-04-20 CA CA2563461A patent/CA2563461C/en not_active Expired - Fee Related
- 2005-04-20 BR BRPI0510451-3A patent/BRPI0510451A/pt not_active IP Right Cessation
- 2005-04-20 WO PCT/EP2005/004199 patent/WO2005105754A1/en not_active Ceased
- 2005-04-20 ES ES05735100T patent/ES2324674T3/es not_active Expired - Lifetime
- 2005-04-26 US US11/114,404 patent/US20050245589A1/en not_active Abandoned
-
2009
- 2009-10-21 US US12/582,755 patent/US20100035953A1/en not_active Abandoned
-
2011
- 2011-06-03 US US13/152,756 patent/US20110237640A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| WO2005105754A1 (en) | 2005-11-10 |
| EP1742923A1 (de) | 2007-01-17 |
| JP2007534715A (ja) | 2007-11-29 |
| JP4733692B2 (ja) | 2011-07-27 |
| RU2006141686A (ru) | 2008-06-10 |
| EP1742923B1 (de) | 2009-05-27 |
| RU2384573C2 (ru) | 2010-03-20 |
| DE602005014629D1 (de) | 2009-07-09 |
| BRPI0510451A (pt) | 2007-10-30 |
| CN1946698B (zh) | 2010-12-01 |
| CN1946698A (zh) | 2007-04-11 |
| CA2563461A1 (en) | 2005-11-10 |
| US20110237640A1 (en) | 2011-09-29 |
| ES2324674T3 (es) | 2009-08-12 |
| US20050245589A1 (en) | 2005-11-03 |
| KR20070002071A (ko) | 2007-01-04 |
| MXPA06012093A (es) | 2007-01-25 |
| AU2005238163A1 (en) | 2005-11-10 |
| US20100035953A1 (en) | 2010-02-11 |
| KR100815691B1 (ko) | 2008-03-20 |
| CA2563461C (en) | 2012-12-11 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EA201001669A1 (ru) | Замещенные пиримидин-5-карбоксамиды 281 | |
| EA201001585A1 (ru) | Производные тиенопиридона в качестве активаторов амр-активированной протеинкиназы (амрк) | |
| EA201001733A1 (ru) | Производные тиенопиридона в качестве активаторов амр-активированной протеинкиназы (амрк) | |
| NZ592425A (en) | Isoindoline compounds for use in the treatment of cancer | |
| MA37891A1 (fr) | Alcoxypyrazoles comme activateurs de guanylate cyclase soluble | |
| MY138906A (en) | Phenyl derivatives as ppar agonists | |
| MY157116A (en) | Novel seh inhibitors and their use | |
| PT2323972E (pt) | Compostos de tetraciclina substituídos com c7-flúor | |
| NO20090979L (no) | (3-amino-1,2,3,4-tetrahydro-9H-karbazol-9-yl)-eddiksyrederivater | |
| EA200870302A1 (ru) | 1,3-диоксанкарбоновые кислоты | |
| EA200802223A1 (ru) | 1,5-дифенилпиразолы ii в качестве ингибиторов hsp90 | |
| MX2009012613A (es) | Tiazoles substituidos por heteroarilo y su uso como agentes antivirales. | |
| MX2009009238A (es) | Nuevos inhibidores de fosfodiesterasa. | |
| EA200802173A1 (ru) | Производные терфенила для лечения болезни альцгеймера | |
| DE602007001463D1 (de) | Pyrimidin-, chinazolin-, pteridin- und triazinderivate | |
| DE602004008959D1 (de) | Benzoäbüä1,4üdioxepinderivate | |
| MX2010001020A (es) | Derivados de pirimidina utiles para el tratamiento de condiciones inflamatorias o alergicas. | |
| TN2009000483A1 (fr) | Derives de 7-alkynyl-1-8-naphthyridones, leur preparation et leur application en therapeutique | |
| IN2012DN02502A (de) | ||
| TW200616979A (en) | Non-nucleoside reverse transcriptase inhibitors | |
| TW200700069A (en) | Benzothiazole, thiazolopyridine, benzooxazole and oxazolopyridine derivatives | |
| MY143568A (en) | 11b-hsd1 inhibitors for the treatment of diabetes | |
| TW200716547A (en) | Piperidin-4-yl-amide derivatives | |
| ATE492534T1 (de) | 1h-indol-5-ylpiperazin-1-ylmethanonderivate | |
| ATE512142T1 (de) | Pyrimidin- und chinazolinderivate als modulatoren der somatostatin-rezeptor aktivität |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| UEP | Publication of translation of european patent specification |
Ref document number: 1742923 Country of ref document: EP |